MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 265 filers reported holding MYRIAD GENETICS INC in Q4 2018. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $410,000 | -27.3% | 14,100 | -26.2% | 0.03% | +13.0% |
| Q1 2018 | $564,000 | -56.9% | 19,100 | -72.0% | 0.02% | -61.7% |
| Q1 2017 | $1,309,000 | +60.6% | 68,200 | +39.5% | 0.06% | +22.4% |
| Q4 2016 | $815,000 | -77.7% | 48,900 | -59.0% | 0.05% | -73.1% |
| Q2 2016 | $3,651,000 | +596.8% | 119,317 | +751.2% | 0.18% | +691.3% |
| Q1 2016 | $524,000 | -87.4% | 14,017 | -85.4% | 0.02% | -88.3% |
| Q4 2015 | $4,144,000 | +589.5% | 96,017 | +498.3% | 0.20% | +790.9% |
| Q3 2015 | $601,000 | -70.1% | 16,049 | -83.3% | 0.02% | -79.4% |
| Q4 2013 | $2,011,000 | -35.9% | 95,867 | -28.2% | 0.11% | -37.4% |
| Q3 2013 | $3,136,000 | -40.3% | 133,479 | -31.7% | 0.17% | -0.6% |
| Q2 2013 | $5,252,000 | – | 195,462 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |